Yoshito Zamami

Okayama University — Japan

Neuroscience · Life Sciences

29h-index2.9kcitations274works2.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neuropeptides and Animal Physiology(19), Cancer Immunotherapy and Biomarkers(18), Nitric Oxide and Endothelin Effects(17), Cardiovascular, Neuropeptides, and Oxidative Stress Research(16), Lung Cancer Treatments and Mutations(13)

Publications274 total

Incidence and Impact of Odontogenic Infection-Related Febrile Episodes During Perioperative Doxorubicin-Cyclophosphamide or Docetaxel-Cyclophosphamide Chemotherapy for Breast Cancer
2026Open Access
Global trends in Sarcoidosis-Associated Mortality, 2001 – 2023: Insights from the WHO Mortality Database
Annals of the American Thoracic Society·2026
Serum Albumin Predicts Immune-Related Adverse Events and Outcomes in Non–Small Cell Lung Cancer
2026Open Access
Exploratory Analysis for Development Predictive Models of Immune Checkpoint Inhibitor-Induced Myocarditis Using a Nationwide Claims Database
Biological and Pharmaceutical Bulletin·2026Open Access
Global trends in Clostridioides difficile infection–related mortality, 2001-2023: An observational study
International Journal of Infectious Diseases·2025Open Access
Drug interaction (64. Drug interactions of anti-cytomegalovirus agents)
Okayama Igakkai Zasshi (Journal of Okayama Medical Association)·2025
Effectiveness of Statins for Oxaliplatin‐Induced Peripheral Neuropathy: A Multicenter Retrospective Observational Study
Clinical and Translational Science·2025Open Access
Risk of Heart Failure Hospitalization in Patients Treated With Osimertinib
JACC CardioOncology·2025· 2 citedOpen Access
An integrative drug discovery strategy using real-world data, in silico modeling, and network pharmacology
Folia Pharmacologica Japonica·2025
Cardiotoxicity Assessment of EGFR Tyrosine Kinase Inhibitors Using Human iPS Cell‐Derived Cardiomyocytes and FDA Adverse Events Reporting System
Clinical and Translational Science·2025Open Access
Drug interaction (63. Precautions for the use of antifungal agents from the perspective of drug–drug interactions)
Okayama Igakkai Zasshi (Journal of Okayama Medical Association)·2025
Global trends in mortality related to pulmonary embolism: an epidemiological analysis of data from the World Health Organization mortality database from 2001 to 2023
EClinicalMedicine·2025· 5 citedOpen Access
Pharmacovigilance study for the identification of mogamulizumab-induced immune-related adverse events using a real-world database
The Oncologist·2025· 1 citedOpen Access
Identifying New Candidate Predictors of Mortality in Japanese Patients with Severe Drug Eruptions
Drug Safety·2025· 1 cited
Unravelling the cardioprotective effects of calcitriol in Sunitinib-induced toxicity: A comprehensive in silico and in vitro study
Biomedicine & Pharmacotherapy·2025· 1 citedOpen Access
Trends in nontuberculous mycobacterial disease mortality based on 2000-2022 data from 83 countries
International Journal of Infectious Diseases·2025· 10 citedOpen Access
Comprehensive analysis of adverse event profile changes with pertuzumab addition to trastuzumab‐based breast cancer therapy: Disproportionality analysis using VigiBase
British Journal of Clinical Pharmacology·2025
Promotion of the appropriate use of antimicrobial agents by utilizing medical big data
Folia Pharmacologica Japonica·2025
Time dependent predictors of cardiac inflammatory adverse events in cancer patients receiving immune checkpoint inhibitors
Cardio-Oncology·2025Open Access
Incidence of Myocarditis Caused by Drugs Used for Ulcerative Colitis as Examined Using VigiBase, a Spontaneous Adverse Drug Reaction Reporting Database
Biological and Pharmaceutical Bulletin·2025Open Access
page 1 of 14Next →

Frequent Co-authors

Keisuke Ishizawa(20), Mitsuhiro Goda(18), Yuki Izawa‐Ishizawa(17), Kenshi Takechi(16), Shingo Takatori(14), Hiromu Kawasaki(14), Masaki Imanishi(13), Hirofumi Hamano(13), Toshihiro Koyama(12), Masayuki Chuma(12), Yoshihisa Kitamura(12), Yasumasa Ikeda(12), Yuya Horinouchi(12), Takahiro Niimura(11), Koichiro Tsuchiya(10), Toshiaki Tamaki(10), Naoto Okada(8), Keijo Fukushima(8), Xin Jin(7), Licht Miyamoto(7)